Monocarboxylate transporter MCT1 is a target for immunosuppression - Nature Chemical Biology
- ️Donald, David K
- ️Sun Oct 30 2005
- Letter
- Published: 30 October 2005
- Raymond Hutchinson1,
- John R Bantick2,
- Graham P Belfield3,
- Amanda D Benjamin1,
- Diana Brazma1 nAff5,
- Robert V Bundick1,
- I David Cook1 nAff6,
- Robert I Craggs1,
- Susan Edwards1,
- Leslie R Evans3 nAff7,
- Richard Harrison2,
- Elain Holness1,
- Andrew P Jackson3,
- Clive G Jackson3,
- Lee P Kingston2,
- Matthew W D Perry2,
- Andrew R J Ross3,
- Paul A Rugman1,
- Sasvinder S Sidhu1,
- Michael Sullivan3 nAff8,
- David A Taylor-Fishwick1 nAff9,
- P Craig Walker3,
- Yvonne M Whitehead1,
- David J Wilkinson2,
- Andrew Wright4 &
- …
- David K Donald2
Nature Chemical Biology volume 1, pages 371–376 (2005)Cite this article
-
3654 Accesses
-
12 Altmetric
Abstract
Current immunosuppressive therapies act on T lymphocytes by modulation of cytokine production, modulation of signaling pathways or by inhibition of the enzymes of nucleotide biosynthesis. We have identified a previously unknown series of immunomodulatory compounds that potently inhibit human and rat T lymphocyte proliferation in vitro and in vivo in immune-mediated animal models of disease, acting by a novel mechanism. Here we identify the target of these compounds, the monocarboxylate transporter MCT1 (SLC16A1)1, using a strategy of photoaffinity labeling and proteomic characterization. We show that inhibition of MCT1 during T lymphocyte activation results in selective and profound inhibition of the extremely rapid phase of T cell division essential for an effective immune response. MCT1 activity, however, is not required for many stages of lymphocyte activation, such as cytokine production, or for most normal physiological functions. By pursuing a chemistry-led target identification strategy, we have discovered that MCT1 is a previously unknown target for immunosuppressive therapy and have uncovered an unsuspected role for MCT1 in immune biology.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Additional access options:
Similar content being viewed by others
References
Halestrap, A.P. & Meredith, D. The SLC16 gene family - from monocarboxylate transporters (MCTs) to aromatic amino acid transporters and beyond. Pflugers Arch. 447, 619–628 (2004).
Michne, W.F. et al. Novel inhibitors of the nuclear factor of activated T cells (NFAT)-mediated transcription of β-galactosidase: potential immunosuppressive and antiinflammatory agents. J. Med. Chem. 38, 2557–2569 (1995).
Cheshire, D. et al. Novel compounds. Patent WO9854190. (1998).
Bantick, J.R., Cooper, M.E., Thorne, P. & Perry, M.W.D. Novel compounds. Patent WO9929695. (1999).
Ford, W.L., Burr, W. & Simonsen, M. A lymph node weight assay for the graft-versus-host activity of rat lymphoid cells. Transplantation 10, 258–266 (1970).
Larsson, P., Kleinau, S., Holmdahl, R. & Klareskog, L. Homologous type II collagen-induced arthritis in rats. Arthritis Rheum. 33, 693–701 (1990).
Baine, Y. et al. Functional characterization of novel IL-2 transcriptional inhibitors. J. Immunol. 154, 3667–3677 (1995).
Mempel, T.R., Henrickson, S.E. & von Andrian, U.H. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases. Nature 427, 154–159 (2004).
Poole, R.C., Sansom, C.E. & Halestrap, A.P. Studies on the membrane topology of the rat erythrocyte H+/lactate cotransporter (MCT1). Biochem. J. 320, 817–824 (1996).
Ishihara, H., Wang, H., Drewes, L.R. & Wollheim, C.B. Overexpression of monocarboxylate transporter and lactate dehydrogenase alters insulin secretory responses to pyruvate and lactate in β cells. J. Clin. Invest. 104, 1621–1629 (1999).
Wang, X., Levi, A.J. & Halestrap, A.P. Kinetics of the sarcolemmal lactate carrier in single heart cells using BCECF to measure pHi . Am. J. Physiol. 267, H1759–H1769 (1994).
Halestrap, A.P. & Price, N.T. The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation. Biochem. J. 343, 281–299 (1999).
Guppy, M., Greiner, E. & Brand, K. The role of the Crabtree effect and an endogenous fuel in the energy metabolism of resting and proliferating thymocytes. Eur. J. Biochem. 212, 95–99 (1993).
Bental, M. & Deutsch, C. Metabolic changes in activated T cells: an NMR study of human peripheral blood lymphocytes. Magn. Reson. Med. 29, 317–326 (1993).
Frauwirth, K.A. et al. The CD28 signaling pathway regulates glucose metabolism. Immunity 16, 769–777 (2002).
Wilson, M.C. et al. Lactic acid efflux from white skeletal muscle is catalyzed by the monocarboxylate transporter isoform MCT3. J. Biol. Chem. 273, 15920–15926 (1998).
Dimmer, K-S., Friedrich, B., Lang, F., Deitmer, J.W. & Broer, S. The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem. J. 350, 219–227 (2000).
Manning Fox, J.E., Meredith, D. & Halestrap, A.P. Characterisation of human monocarboxylate transporter 4 substantiates its role in lactic acid efflux from skeletal muscle. J. Physiol. (Lond.) 529, 285–293 (2000).
Lee, W.-N.P. et al. Mass isotopomer study of the nonoxidative pathways of the pentose cycle with [1,2-13C2]glucose. Am. J. Physiol. 274, E843–E851 (1998).
Buttgereit, F. & Brand, M.D. A hierarchy of ATP-consuming processes in mammalian cells. Biochem. J. 312, 163–167 (1995).
Fairbanks, L.D., Bofill, M., Ruckemann, K. & Simmonds, H.A. Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors. J. Biol. Chem. 270, 29682–29689 (1995).
Frauwirth, K.A. & Thompson, C.B. Regulation of T-lymphocyte metabolism. J. Immunol. 172, 4661–4665 (2004).
Bental, M. & Deutsch, C. 19F-NMR study of primary human T lymphocyte activation: effects of mitogen on intracellular pH. Am. J. Physiol. 266, C541–C551 (1994).
Daberkow, R.L., White, B.R., Cederberg, R.A., Griffin, J.B. & Zempleni, J. Monocarboxylate transporter 1 mediates biotin uptake in human peripheral blood mononuclear cells. J. Nutr. 133, 2703–2706 (2003).
Dröge, W., Roth, S., Altmann, A. & Mihm, S. Regulation of T-cell functions by L-lactate. Cell. Immunol. 108, 405–416 (1987).
Roth, S. & Dröge, W. Regulation of interleukin 2 production, interleukin 2 mRNA expression and intracellular glutathione levels in ex vivo derived T lymphocytes by lactate. Eur. J. Immunol. 21, 1933–1937 (1991).
Kirk, P. et al. CD147 is tightly associated with lactate transporters MCT1 and MCT4 and facilitates their cell surface expression. EMBO J. 19, 3896–3904 (2000).
Renno, T. et al. A role for CD147 in thymic development. J. Immunol. 168, 4946–4950 (2002).
Staffler, G. et al. Selective inhibition of T cell activation via CD147 through novel modulation of lipid rafts. J. Immunol. 171, 1707–1714 (2003).
Acknowledgements
We thank A. Baines for helpful advice on protein purification from red blood cells and K. Wood, D. Cantrell and A. Halestrap for helpful advice and discussions. We thank K. Jolley for technical assistance in analyzing glucose metabolites by GC-MS, E. Newboult and S. Cartlidge for tumor cell proliferation studies and M. Erlansson and L. Jansson for the CIA model. We gratefully acknowledge the assistance of S. Guile and R. Mohammed in collating the chemical synthesis and analysis information.
Author information
Author notes
Diana Brazma
Present address: Department of Academic Haematology, Royal Free and University College Medical School, London, NW3 2PF, UK
I David Cook
Present address: Global Discovery Enabling Capabilities and Sciences, AstraZeneca R&D Alderley Park, Cheshire, SK10 4TG, UK
Leslie R Evans
Present address: Delta Biotechnology Ltd., Castle Court, 59 Castle Boulevard, Nottingham, NG7 1ED, UK
Michael Sullivan
Present address: Advanced Science and Technology Lab, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, Leicestershire, LE11 5RH, UK
David A Taylor-Fishwick
Present address: Cell and Molecular Biology, Diabetes Research Institute, Eastern Virginia Medical School, Norfolk, Virginia, 23510, USA
Authors and Affiliations
Department of Discovery BioScience, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, UK
Clare M Murray, Raymond Hutchinson, Amanda D Benjamin, Diana Brazma, Robert V Bundick, I David Cook, Robert I Craggs, Susan Edwards, Elain Holness, Paul A Rugman, Sasvinder S Sidhu, David A Taylor-Fishwick & Yvonne M Whitehead
Department of Medicinal Chemistry, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, UK
John R Bantick, Richard Harrison, Lee P Kingston, Matthew W D Perry, David J Wilkinson & David K Donald
Department of Molecular Biology, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, UK
Graham P Belfield, Leslie R Evans, Andrew P Jackson, Clive G Jackson, Andrew R J Ross, Michael Sullivan & P Craig Walker
Departments of Physical and Metabolic Science, AstraZeneca R&D Charnwood, Bakewell Road, Loughborough, LE11 5RH, Leicestershire, UK
Andrew Wright
Authors
- Clare M Murray
You can also search for this author in PubMed Google Scholar
- Raymond Hutchinson
You can also search for this author in PubMed Google Scholar
- John R Bantick
You can also search for this author in PubMed Google Scholar
- Graham P Belfield
You can also search for this author in PubMed Google Scholar
- Amanda D Benjamin
You can also search for this author in PubMed Google Scholar
- Diana Brazma
You can also search for this author in PubMed Google Scholar
- Robert V Bundick
You can also search for this author in PubMed Google Scholar
- I David Cook
You can also search for this author in PubMed Google Scholar
- Robert I Craggs
You can also search for this author in PubMed Google Scholar
- Susan Edwards
You can also search for this author in PubMed Google Scholar
- Leslie R Evans
You can also search for this author in PubMed Google Scholar
- Richard Harrison
You can also search for this author in PubMed Google Scholar
- Elain Holness
You can also search for this author in PubMed Google Scholar
- Andrew P Jackson
You can also search for this author in PubMed Google Scholar
- Clive G Jackson
You can also search for this author in PubMed Google Scholar
- Lee P Kingston
You can also search for this author in PubMed Google Scholar
- Matthew W D Perry
You can also search for this author in PubMed Google Scholar
- Andrew R J Ross
You can also search for this author in PubMed Google Scholar
- Paul A Rugman
You can also search for this author in PubMed Google Scholar
- Sasvinder S Sidhu
You can also search for this author in PubMed Google Scholar
- Michael Sullivan
You can also search for this author in PubMed Google Scholar
- David A Taylor-Fishwick
You can also search for this author in PubMed Google Scholar
- P Craig Walker
You can also search for this author in PubMed Google Scholar
- Yvonne M Whitehead
You can also search for this author in PubMed Google Scholar
- David J Wilkinson
You can also search for this author in PubMed Google Scholar
- Andrew Wright
You can also search for this author in PubMed Google Scholar
- David K Donald
You can also search for this author in PubMed Google Scholar
Corresponding author
Correspondence to Clare M Murray.
Ethics declarations
Competing interests
The authors are either current or former employees of Astra Zeneca p/c.
Supplementary information
Rights and permissions
About this article
Cite this article
Murray, C., Hutchinson, R., Bantick, J. et al. Monocarboxylate transporter MCT1 is a target for immunosuppression. Nat Chem Biol 1, 371–376 (2005). https://doi.org/10.1038/nchembio744
Received: 06 July 2005
Accepted: 03 October 2005
Published: 30 October 2005
Issue Date: December 2005
DOI: https://doi.org/10.1038/nchembio744